l-DOPA reverses the MPTP-induced elevation of the arrestin2 and GRK6 expression and enhanced ERK activation in monkey brain

Abercrombie, 1946, Estimation of nuclear population from microtome sections, Anat. Rec., 94, 239, 10.1002/ar.1090940210 Ahn, 2003, Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference, Proc. Natl. Acad. Sci. U. S. A., 100, 1740, 10.1073/pnas.262789099 Arriza, 1992, The G-protein-coupled receptor kinases bARK1 and bARK2 are widely distributed at synapses in rat brain, J. Neurosci., 12, 4045, 10.1523/JNEUROSCI.12-10-04045.1992 Barrett, 2003, Evidence that a single nucleotide polymorphism in the promoter of the G protein receptor kinase 3 gene is associated with bipolar disorder, Mol. Psychiatry, 8, 546, 10.1038/sj.mp.4001268 Benovic, 1993, Molecular cloning and expression of GRK6. A new member of the G protein-coupled receptor kinase family, J. Biol. Chem., 268, 19521, 10.1016/S0021-9258(19)36546-9 Berke, 1998, A complex program of striatal gene expression induced by dopaminergic stimulation, J. Neurosci., 18, 5301, 10.1523/JNEUROSCI.18-14-05301.1998 Bezard, 1998, Compensatory mechanisms in experimental and human parkinsonism: towards a dynamic approach, Prog. Neurobiol., 55, 93, 10.1016/S0301-0082(98)00006-9 Bezard, 2001, Pathophysiology of levodopa-induced dyskinesia: potential for new therapies, Nat. Rev., Neurosci., 2, 577, 10.1038/35086062 Bezard, 2001, Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of Parkinson's disease, J. Neurosci., 21, 6853, 10.1523/JNEUROSCI.21-17-06853.2001 Bezard, 2003, Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function, Nat. Med., 9, 762, 10.1038/nm875 Bezard, 2003, Presymptomatic compensation in Parkinson's disease is not dopamine-mediated, Trends Neurosci., 26, 215, 10.1016/S0166-2236(03)00038-9 Bohn, 1999, Enhanced morphine analgesia in mice lacking beta-arrestin2, Science, 286, 2495, 10.1126/science.286.5449.2495 Bordet, 1997, Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa, Proc. Nat. Acad. Sci. U. S. A., 94, 3363, 10.1073/pnas.94.7.3363 Cai, 2000, Activation of extracellular signal-regulated protein kinases is associated with a sensitized locomotor response to D(2) dopamine receptor stimulation in unilateral 6-hydroxydopamine-lesioned rats, J. Neurosci., 20, 1849, 10.1523/JNEUROSCI.20-05-01849.2000 Cotzias, 1969, Modification of Parkinsonism by chronic treatment with l-DOPA, N. Engl. J. Med., 280, 337, 10.1056/NEJM196902132800701 Ehringer, 1960, Verteilung von noradrenalin und dopamin (3-hydroxytyramin) im gehirn des menschen und ihr verhalten bei erkrankungen des extrapyramidalen systems, Klin. Wochenschr., 38, 1236, 10.1007/BF01485901 Elsworth, 1998, Upregulation of striatal D2 receptors in the MPTP-treated vervet monkey is reversed by grafts of fetal ventral mesencephalon: an autoradiographic study, Brain Res., 795, 55, 10.1016/S0006-8993(98)00252-2 Frechilla, 2001, Serotonin 5-HT(1A) receptor expression is selectively enhanced in the striosomal compartment of chronic parkinsonian monkeys, Synapse, 39, 288, 10.1002/1098-2396(20010315)39:4<288::AID-SYN1011>3.0.CO;2-V Gainetdinov, 1999, Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice, Neuron, 24, 1029, 10.1016/S0896-6273(00)81048-X Gainetdinov, 2003, Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice, Neuron, 38, 291, 10.1016/S0896-6273(03)00192-2 Gerfen, 2000, Dopamine-mediated gene regulation in models of Parkinson's disease, Ann. Neurol., 47, S42 Gerfen, 2002, D1 dopamine receptor supersensitivity in the dopamine-depleted striatum results from a switch in the regulation of ERK1/2 kinase, J. Neurosci., 22, 5042, 10.1523/JNEUROSCI.22-12-05042.2002 Grondin, 1999, Dopamine D1 receptor mRNA and receptor levels in the striatum of MPTP monkeys chronically treated with SKF-82958, Eur. J. Pharmacol., 378, 259, 10.1016/S0014-2999(99)00482-3 Guillin, 2001, BDNF controls dopamine D3 receptor expression and triggers behavioral sensitization, Nature, 411, 86, 10.1038/35075076 Gurevich, 2003, The new face of active receptor bound arrestin attracts new partners, Structure, 11, 1037, 10.1016/S0969-2126(03)00184-9 Gurevich, 2004, The molecular acrobatics of arrestin activation, TIPS, 25, 59 Gurevich, 1995, Arrestin interaction with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, b2-adrenergic, and m2 muscarinic cholinergic receptors, J. Biol. Chem., 270, 720, 10.1074/jbc.270.2.720 Gurevich, 1997, Agonist-receptor-arrestin, an alternative ternary complex with high agonist affinity, J. Biol. Chem., 272, 28849, 10.1074/jbc.272.46.28849 Gurevich, 2002, Arrestin2 and arrestin3 are differentially expressed in the rat brain during postnatal development, Neuroscience, 109, 421, 10.1016/S0306-4522(01)00511-5 Haber, 2003, The primate basal ganglia: parallel and integrative networks, J. Chem. Neuroanat., 26, 317, 10.1016/j.jchemneu.2003.10.003 Hall, 2002, Regulation of G protein-coupled receptor signaling by scaffold proteins, Circ. Res., 91, 672, 10.1161/01.RES.0000037000.74258.03 Heimer, 2003, A new anatomical framework for neuropsychiatric disorders and drug abuse, Am. J. Psychiatry, 160, 1726, 10.1176/appi.ajp.160.10.1726 Herrero, 1996, Effects of l-DOPA-therapy on dopamine D2 receptor mRNA expression in the striatum of MPTP-intoxicated parkinsonian monkeys, Brain Res. Mol. Brain Res., 42, 149, 10.1016/S0169-328X(96)00157-X Horie, 2000, Retrovirally mediated transfer of a G protein-coupled receptor kinase (GRK) dominant-negative mutant enhances endogenous calcitonin receptor signaling in Chinese hamster ovary cells. GRK inhibition enhances expression of receptors and receptor mRNA, J. Biol. Chem., 275, 29433, 10.1074/jbc.M003413200 Iaccarino, 1998, Myocardial overexpression of GRK3 in transgenic mice: evidence for in vivo selectivity of GRKs, Am. J. Physiol., 275, 1298 Iaccarino, 1998, Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by β-adrenergic receptor stimulation and blockade, Circulation, 98, 1783, 10.1161/01.CIR.98.17.1783 Iaccarino, 1999, Myocardial G protein-coupled receptor kinases: implications for heart failure therapy, Proc. Assoc. Am. Physicians, 111, 399, 10.1111/paa.1999.111.5.399 Joyce, 2002, Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptors, Brain Res., 955, 138, 10.1016/S0006-8993(02)03396-6 Kim, 1993, Expression and characterization of two beta-adrenergic receptor kinase isoforms using the baculovirus expression system, Receptor, 3, 39 Kim, 2001, Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and beta-arrestins, J. Biol. Chem., 276, 37409, 10.1074/jbc.M106728200 Koch, 1995, Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor, Science, 268, 1350, 10.1126/science.7761854 Kohout, 2001, Beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking, Proc. Natl. Acad. Sci. U. S. A., 98, 1601 Krupnick, 1998, The role of receptor kinases and arrestins in G protein-coupled receptor regulation, Annu. Rev. Pharmacol. Toxicol., 38, 289, 10.1146/annurev.pharmtox.38.1.289 Kunapuli, 1994, Expression, purification, and characterization of the G protein-coupled receptor kinase GRK5, J. Biol. Chem., 269, 1099, 10.1016/S0021-9258(17)42226-5 Lastres-Becker, 2001, Increased cannabinoid CB1 receptor binding and activation of GTP-binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP-treated marmosets, Eur. J. Neurosci., 14, 1827, 10.1046/j.0953-816x.2001.01812.x Lévesque, 1995, A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons, Proc. Nat. Acad. Sci. U. S. A., 92, 1719, 10.1073/pnas.92.5.1719 Loudon, 1994, Expression, purification, and characterization of the G protein-coupled receptor kinase GRK6, J. Biol. Chem., 269, 22691, 10.1016/S0021-9258(17)31701-5 Luttrell, 2001, Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds, Proc. Nat. Acad. Sci. U. S. A., 98, 2449, 10.1073/pnas.041604898 Ménard, 1996, Members of the G protein-coupled receptor kinase family that phosphorylate the β2-adrenergic receptor facilitate sequestration, Biochemistry, 35, 4155, 10.1021/bi952961+ Miller, 2000, beta-Arrestin1 interacts with the catalytic domain of the tyrosine kinase c-SRC. Role of beta-arrestin1-dependent targeting of c-SRC in receptor endocytosis, J. Biol. Chem., 275, 11312, 10.1074/jbc.275.15.11312 Morissette, 1996, Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of l-3,4-dihydroxyphenylalanine, Mol. Pharmacol., 50, 1073 Morissette, 1998, Associative and limbic regions of monkey striatum express high levels of dopamine D3 receptors: effects of MPTP and dopamine agonist replacement therapies, Eur. J. Neurosci., 10, 2565, 10.1046/j.1460-9568.1998.00264.x Mundell, 1998, Enhanced expression of G protein-coupled receptor kinase 2 selectively increases the sensitivity of A2A adenosine receptors to agonist-induced desensitization, Br. J. Pharmacol., 125, 347, 10.1038/sj.bjp.0702081 Mundell, 1999, Characterization of G protein-coupled receptor regulation in antisense mRNA-expressing cells with reduced arrestin levels, Biochemistry, 38, 8723, 10.1021/bi990361v Muriel, 1999, Levodopa induces a cytoplasmic localization of D1 dopamine receptors in striatal neurons in Parkinson's disease, Ann. Neurol., 46, 103, 10.1002/1531-8249(199907)46:1<103::AID-ANA15>3.0.CO;2-Z Oakley, 2000, Differential affinities of visual arrestin, barrestin1, and barrestin2 for G protein-coupled receptors delineate two major classes of receptors, J. Biol. Chem., 275, 17201, 10.1074/jbc.M910348199 Orsini, 1998, Characterization of dominant negative arrestins that inhibit beta-2-adrenergic receptor internalization by distinct mechanisms, J. Biol. Chem., 273, 34616, 10.1074/jbc.273.51.34616 Pan, 2003, The nature of the arrestin x receptor complex determines the ultimate fate of the internalized receptor, J. Biol. Chem., 278, 11623, 10.1074/jbc.M209532200 Pierce, 2001, New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades, Oncogene, 20, 1532, 10.1038/sj.onc.1204184 Premont, 1994, Identification, purification, and characterization of GRK5, a member of the family of G protein-coupled receptor kinases, J. Biol. Chem., 269, 6832, 10.1016/S0021-9258(17)37451-3 Quik, 2000, Expression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment, Neuroscience, 98, 263, 10.1016/S0306-4522(00)00130-5 Richardson, 1993, Agonist-induced phosphorylation and desensitization of human m2 muscarinic cholinergic receptors in Sf9 insect cells, J. Biol. Chem., 267, 22249, 10.1016/S0021-9258(18)41662-6 Rockman, 1996, Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice, Proc. Nat. Acad. Sci. U. S. A., 93, 9954, 10.1073/pnas.93.18.9954 Ryoo, 1998, Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease, Mov. Disord., 13, 788, 10.1002/mds.870130506 Sallese, 1997, G protein-coupled receptor kinase GRK4. Molecular analysis of the four isoforms and ultrastructural localization in spermatozoa and germinal cells, J. Biol. Chem., 272, 10188, 10.1074/jbc.272.15.10188 Sterne-Marr, 1993, Polypeptide variants of beta-arrestin and arrestin3, J. Biol. Chem., 268, 15640, 10.1016/S0021-9258(18)82304-3 Stocchi, 1997, Strategies for treating patients with advanced Parkinson's disease with disastrous fluctuations and dyskinesias, Clin. Neuropharmacol., 20, 95, 10.1097/00002826-199704000-00001 Todd, 1996, Dynamic changes in striatal dopamine D2 and D3 receptor protein and mRNA in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) denervation in baboons, J. Neurosci., 16, 7776, 10.1523/JNEUROSCI.16-23-07776.1996 Tohgo, 2002, beta-Arrestin scaffolding of the ERK cascade enhances cytosolic ERK activity but inhibits ERK-mediated transcription following angiotensin AT1a receptor stimulation, J. Biol. Chem., 277, 9429, 10.1074/jbc.M106457200 Tohgo, 2003, The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation, J. Biol. Chem., 278, 6258, 10.1074/jbc.M212231200 Wade, 2001, Changes in striatal dopamine D3 receptor regulation during expression of and recovery from MPTP-induced parkinsonism, Brain Res., 905, 111, 10.1016/S0006-8993(01)02513-6 Walker, 1999, Altered airway and cardiac responses in mice lacking G protein-coupled receptor kinase 3, Am. J. Physiol., 276, R1214 Willets, 1999, Selective reduction in A2 adenosine receptor desensitization following antisense-induced suppression of G protein-coupled receptor kinase 2 expression, J. Neurochem., 73, 1781